Add Company
Join Now

Proteovant Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Proteovant Therapeutics's estimated annual revenue is currently $10.8M per year.(i)
  • Proteovant Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Proteovant Therapeutics has 70 Employees.(i)
  • Proteovant Therapeutics grew their employee count by 63% last year.

Proteovant Therapeutics's People

NameTitleEmail/Phone
1
VP, Head Molecular TechnologyReveal Email/Phone
2
VP, Head DMPKReveal Email/Phone
3
Director, BiologyReveal Email/Phone
4
Senior DirectorReveal Email/Phone
5
Director, BiologyReveal Email/Phone
6
Associate Director, Computational BiologyReveal Email/Phone
7
Associate Director Discovery ChemistryReveal Email/Phone
8
Senior Director Medicinal ChemistryReveal Email/Phone
9
Senior Director Biochemistry and BiophysicsReveal Email/Phone
10
Director Structural BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Proteovant Therapeutics?

We are Protein Degraders. At Proteovant, our team possesses the scientific knowledge, proprietary technologies, business acumen and risk tolerance required to unlock this pioneering field of science and ultimately deliver disease-modifying therapies for patients. We harness the human body’s natural protein degradation machinery to discover and develop transformative new medicines to treat patients with life-altering diseases. With our approach, we are able to pursue previously undruggable disease targets and pioneer this expansive field with speed and scale. We integrate extensive medicinal chemistry and biology intuition with deep, proprietary artificial intelligence capabilities – resulting in a robust pipeline that spans a range of therapeutic areas and novel molecular targets. We are funded by Roivant Sciences and SK Holdings. For more information, please visit our website at www.proteovant.com

keywords:N/A

N/A

Total Funding

70

Number of Employees

$10.8M

Revenue (est)

63%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.3M7023%N/A
#2
$15.3M700%N/A
#3
$15M70N/AN/A
#4
$22.2M7025%N/A
#5
$17M706%N/A